CNX-1351
CNX-1351 is a covalent small molecule inhibitor that selectively targets the PI3Kα isoform. It is a valuable research tool for investigating PI3Kα-driven signaling pathways in oncology, applicable in both cellular and animal models of cancer.
Product Specifications
CAS Number
1276105-89-5
Product Name Alternative
Inhibit, Inhibitor, CNX 1351, CNX1351, CNX-1351, Phosphoinositide 3-kinase, PI3K, PI3Kα
Field of Research
Cell Biology, Signal Transduction
Purity
98.83% (May vary between batches)
Solubility
DMSO:5.74 mg/mL (10.01 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (1.74 mM)
Smiles
CC (C) =CC (=O) CCC (=O) N1CCN (Cc2cc3nc (nc (N4CCOCC4) c3s2) -c2cccc3[nH]ncc23) CC1
Molecular Formula
C30H35N7O3S
Molecular Weight
573.71
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MR219204L3V 200 µL
Nlrp9a (NM_001048220) Mouse Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 
C2900-07B 1 mL
Ceruloplasmin (CP, EC 1.16.3.1, Ferroxidase) (Biotin)
Sign In for Pricing
View Details 